A deep dive discussion on Abivax with Truist Senior Biotech Analyst Gregory Renza episode artwork

EPISODE · Dec 29, 2025 · 45 MIN

A deep dive discussion on Abivax with Truist Senior Biotech Analyst Gregory Renza

from BiotechTV - News · host BiotechTV

We discuss the upcoming maintenance data, commercial prospects, Crohn's, and buyout prospects.

We discuss the upcoming maintenance data, commercial prospects, Crohn's, and buyout prospects.

NOW PLAYING

A deep dive discussion on Abivax with Truist Senior Biotech Analyst Gregory Renza

0:00 45:29

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of BiotechTV - News?

This episode is 45 minutes long.

When was this BiotechTV - News episode published?

This episode was published on December 29, 2025.

What is this episode about?

We discuss the upcoming maintenance data, commercial prospects, Crohn's, and buyout prospects.

Can I download this BiotechTV - News episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!